Oobli

Oobli, with the slogan "Seriously sweet proteins," has been making waves since its founding in 2014. The company's innovative approach to creating proteins with a focus on sweetness, rather than sugar, has garnered attention in the Biotechnology, Food and Beverage, Health Care, and Nutrition industries. Oobli's recent $25.00M Series B investment on 27 May 2022 has attracted significant interest from a diverse group of investors including SOSV, Evolv Ventures, Global Brain, Khosla Ventures, IndieBio, Alumni Ventures Blockchain Fund, B37 Ventures, and Piva Capital. This round of investment is a testament to the confidence of these notable investors in Oobli's mission. The company's commitment to creating products that are gut-friendly, diabetic-friendly, and environmentally sustainable aligns with current trends and consumer preferences. Oobli's introduction of their new product, Lemonade, which boasts 80% less sugar, no alternative sweeteners, and is made with real fruit, further demonstrates their dedication to offering healthier alternatives. With its base in the United States, Oobli continues to pave the way in the protein industry and is poised for further growth and success.